Concept information
Terme préférentiel
cyclic peptide
Concept générique
Concepts spécifiques
- 2-[(2R,5S,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
- 2-({[3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(15),5,8,12(16),13-pentaen-4-yl](hydroxy)methylidene}amino)acetic acid
- 2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester
- (2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl]-1-[(3R,6S,9R,12R,15S)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-butan-2-yl-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide
- (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide
- (3S,6S,9S,12R)-3-[(2R)-butan-2-yl]-6-[(1-methoxy-3-indolyl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
- (3S,6S,9S,12R)-3-butan-2-yl-6-[(1-methoxy-3-indolyl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
- 6,9-dimethyl-3-[6-(2-oxiranyl)-6-oxohexyl]-1,4,7,10-tetrazabicyclo[10.3.0]pentadecane-2,5,8,11-tetrone
- 6-benzyl-3-butan-2-yl-9-(7,8-dihydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
- Adouetine X
- Adouetine Y
- Adouetine Z
- Aerucyclamide a
- Americine
- Amphibine A
- Amphibine B
- Apetaline A
- Apetaline B
- Apetaline C
- Aralionine A
- Arginine vasopressin 1-8
- Ascidiacyclamide
- BQ 123
- BQ 518
- Brachystemin F
- Brachystemin G
- Brachystemin H
- Brachystemin I
- Canthiumine
- Ceanothine B
- Crenatine A
- Cyclo(L-Pro-L-Val-L-Val)
- (cyclo(L-Val-D-Ile-L-Leu-L-pro-D-Leu))
- (cyclo(N-methyl-L-Phe-L-Val-D-Ile-L-Leu-L-Pro))
- Epimauritine A
- Epimauritine A N-oxide
- Frangulanine
- Glabrin C
- Glabrin D
- heterodetic cyclic peptide
- homodetic cyclic peptide
- Hymenocardine
- Integerrenine
- Integerressine
- Integerrine
- LSM-36768
- LSM-4991
- LSM-4992
- LSM-5075
- LSM-5352
- LSM-6402
- LSM-6699
- Lyciumin A
- Lyciumin B
- Lyciumin D
- Lypressin
- mauritine A
- Mauritine A N-oxide
- mauritine F
- Mucronine A
- Mucronine B
- Namalide C
- Nostocyclopeptide A1
- Nostocyclopeptide A2
- Nostocyclopeptide A3
- Nummularine A
- Nummularine F
- Pandamine
- Patellamide A
- Patellamide B
- Patellamide C
- Patellamide D
- piperazine-2,5-dione
- Psammosilenin B
- Pyoverdine I
- Rhodopeptin C1
- Scutianine F
- Scytonemide A
- Tunicyclin B
- Tunicyclin C
- Tunicyclin D
- Ustiloxin
- Vignatic acid A
- Vignatic acid B
- Westiellamide
- Wewakazole
- Zizyphine A
- Zizyphine F
Appartient au groupe
URI
http://data.loterre.fr/ark:/67375/KFP-WKRHNPBT-V
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}